ABCL - 313
waveLINE-011: Zilovertamab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) vs Polatuzumab Vedotin Plus R-CHP as First-Line Therapy in Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
Melissa Drysdale
Poster Presenter: Melissa Drysdale